Pharmacologic Reperfusion Therapy with Indigenous Tenecteplase in 15,222 patients with ST Elevation Myocardial Infarction - The Indian Registry.

CONCLUSION: This study confirms the safety and efficacy of indigenous tenecteplase in Indian patients with STEMI, including high risk subgroups. It also highlights the fact that delayed treatment denotes denial of benefits of pharmacologic reperfusion therapy. PMID: 23993004 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23993004?dopt=Abstract

Source: Indian Heart J - July 1, 2013 Category: Cardiology Authors: Iyengar SS, Nair T, Hiremath JS, Jadhav U, Katyal VK, Kumbla D, Sathyamurthy I, Jain RK, Srinivasan M Tags: Indian Heart J Source Type: research